Growth Of Genomic Biomarkers Market Driven By Personalized Medicine Demand: A Significant Driver Propelling The Genomic Biomarkers Market In 2025

The Genomic Biomarkers Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Genomic Biomarkers Market Size and Projected Growth Rate?
The genomic biomarkers market size has experienced rapid growth in recent years. It will grow from $7.42 billion in 2024 to $8.72 billion in 2025 at a compound annual growth rate (CAGR) of 17.4%. This growth is driven by the increased emphasis on genetic testing activities, the rising incidence of chronic diseases, the focus on precision medicine initiatives, the growing adoption of companion diagnostics, and the increasing number of patients with neurological diseases.

The genomic biomarkers market is projected to reach $16.51 billion by 2029, growing at a CAGR of 17.3%. Growth is attributed to the rising incidence of ovarian and gastric cancers, growing genetic testing awareness, and the use of biomarkers in cancer diagnosis. Key trends include NGS advancements, integration with other omics, and innovations in genomic technologies.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19485

What Are the Major Segments in the Genomic Biomarkers Market?
The genomic biomarkersmarket covered in this report is segmented -

1) By Type: Predictive Biomarkers, Prognostic Biomarkers
2) By Disease Indication: Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Other Disease Indications
3) By Validation: Analytical Validation, Clinical Validation, Clinical Utility
4) By End-User: Hospitals, Diagnostic Centers, Other End User

Subsegments:
1) By Predictive Biomarkers: Drug Response Biomarkers, Companion Diagnostics Biomarkers, Pharmacodynamic Biomarkers, Predictive Genetic Markers for Disease Susceptibility
2) By Prognostic Biomarkers: Cancer Prognostic Biomarkers, Cardiovascular Disease Prognostic Biomarkers, Neurodegenerative Disease Prognostic Biomarkers, Infectious Disease Prognostic Biomarkers

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19485&type=smp

What Are The Driving Genomic Biomarkers Market Evolution?
Growing demand for personalized medicine is expected to advance the genomic biomarkers market. This approach uses genetic information to tailor treatment plans. Factors such as EHR usage and genomic tech are fueling this trend. Genomic biomarkers help doctors choose targeted therapies based on an individual's genetic profile. In 2022, the Personalized Medicine Coalition reported that 12 new personalized therapies accounted for 34% of all drug approvals that year. Therefore, the trend toward precision medicine is propelling genomic biomarkers.

Which Firms Dominate The Genomic Biomarkers Market Segments?
Major companies operating in the genomic biomarkers market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd., Illumina Inc., PerkinElmer Inc., Almac Group, Azenta Inc., Novogene Corporation, Oxford Nanopore Technologies Ltd., Celerion, Quanterix Corporation, Bio-Rad Laboratories Inc., NantHealth Inc., Centogene N.V., Sophia Genetics SA, Envisagenics, Deep Genomics, Creative Diagnostics, Macrogen Inc., Guardant Health Inc., Sema4

What Are the Latest Developing Trends in the Genomic Biomarkers Market?
In the genomic biomarkers market, major companies are innovating products like lung reagents to improve the detection of genetic mutations in lung cancer, which helps with accurate diagnosis and personalized treatment. Lung reagents are used in diagnostic tests and medical procedures related to lung health. For example, Biofidelity, a UK company, launched ASPYRE-Lung reagents in December 2023, designed to identify key genetic mutations critical for guiding targeted therapies in lung cancer treatment.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/genomic-biomarkers-global-market-report

Which Is The Largest Region In The Genomic Biomarkers Market?
North America was the largest region in the genomic biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomic biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Genomic Biomarkers Market?
2. What is the CAGR expected in the Genomic Biomarkers Market?
3. What Are the Key Innovations Transforming the Genomic Biomarkers Industry?
4. Which Region Is Leading the Genomic Biomarkers Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.